Ever thought of the difference between an ACL tear and an MCL tear Learn what makes the two different despite being located ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

AstraZeneca has received approval from the FDA for its BTK inhibitor, Calquence (acalabrutinib), for first-line use in MCL.

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

New Treatments for HR-Positive Breast Cancer and Mantle Cell Lymphoma Offer Promising Outcomes and Expanded Options for ...

AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma: Cambridge, UK Monday, January 20, 2025, 09:00 Hrs [IS ...

Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for ...

Medial collateral ligament (MCL) injuries are common in sports and can lead to significant knee instability, particularly anteromedial rotatory instability (AMRI). The MCL plays a crucial role in ...

Lisandro Martínez suffered a serious looking knee injury as a toothless Manchester United slumped to their fifth Premier ...

Lisandro Martinez was left in tears as he was stretchered off with a serious-looking injury. The Manchester United star was ...

The Food and Drug Administration (FDA) has approved Calquence ® (acalabrutinib) in combination with bendamustine and rituximab for the treatment of adults with previously untreated mantle cell ...